MARKET

CDTX

CDTX

Cidara Theraptcs
NASDAQ
220.41
-0.39
-0.18%
After Hours: 220.58 +0.17 +0.08% 19:22 12/29 EST
OPEN
220.80
PREV CLOSE
220.80
HIGH
221.00
LOW
220.41
VOLUME
1.37M
TURNOVER
--
52 WEEK HIGH
221.20
52 WEEK LOW
15.22
MARKET CAP
6.93B
P/E (TTM)
-18.7264
1D
5D
1M
3M
1Y
5Y
1D
Cidara: Merck's Acquisition Based On CD388 Flu Prevention Potential
Seeking Alpha · 1d ago
Weekly Report: what happened at CDTX last week (1222-1226)?
Weekly Report · 1d ago
5 Stocks That Moved the Most in 2025 – What Lies Ahead
TipRanks · 6d ago
Abivax is the top performing biotechnology stock YTD
Seeking Alpha · 12/22 21:07
Top 10 healthcare stocks according to YTD performance, as the sector holds steady
Seeking Alpha · 12/22 14:59
Weekly Report: what happened at CDTX last week (1215-1219)?
Weekly Report · 12/22 10:19
Noteworthy Friday Option Activity: CDTX, STZ, LRCX
NASDAQ · 12/19 20:27
The $100 Club - Were You Early To The Triple-Digit Rally In ABVX, NUTX, BLTE…?
NASDAQ · 12/19 13:15
More
About CDTX
Cidara Therapeutics, Inc. is a biotechnology company. The Company is using its Cloudbreak platform to develop drug-Fc conjugate (DFC), immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. The Company’s Cloudbreak platform enables development of DFCs that inhibit specific disease targets while simultaneously engaging the immune system. The Company’s lead DFC candidate CD388, is a highly potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which has completed Phase I and Phase IIa clinical trials. Its oncology DFC candidate, CBO421, is a development candidate targeting CD73 for the treatment of solid tumors. Its Cloudbreak platform creates single molecule cocktails by coupling targeted small molecules and peptides to a human antibody fragment (Fc). The Company is also advancing multiple preclinical and discovery programs targeting cancer and autoimmune diseases.

Webull offers Cidara Therapeutics Inc stock information, including NASDAQ: CDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDTX stock methods without spending real money on the virtual paper trading platform.